Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Topical Products

Perrigo Triamcinolone Acetonide Cream Recalled for Gritty Texture

Agency Publication Date: August 29, 2022
Share:
Sign in to monitor this recall

Summary

Perrigo Triamcinolone Acetonide Cream USP (0.1%), packaged in 80 g tubes, is being recalled because users have reported a gritty texture and a lack of effectiveness. Approximately 57,816 tubes are included in this recall. The issue was identified after multiple complaints indicated the product was not meeting quality standards and was not working as intended to treat skin conditions.

Risk

The gritty texture and lack of effectiveness suggest the medication may not properly deliver the active ingredient to the skin, potentially leaving medical conditions untreated. While no specific injuries have been reported, the altered texture could also cause minor skin irritation.

What You Should Do

  1. This recall affects 80 g tubes of Perrigo Triamcinolone Acetonide Cream USP, 0.1% (NDC 45802-064-36).
  2. Check your medication tube for lot number 2CT0486 with an expiration date of 02/29/2024.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Padagis US LLC for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Triamcinolone Acetonide Cream USP, 0.1% (80 g tube)by Perrigo
Variants: 0.1%, 80 g tube, Rx Only
Lot Numbers:
2CT0486 (Exp 02/29/2024)
NDC:
45802-064-36

Manufactured By Perrigo, Bronx, NY 10457; Distributed By Perrigo, Allegan, MI 49010.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 90790
Status: Resolved
Manufacturer: Padagis US LLC
Sold By: pharmacies; Perrigo
Manufactured In: United States
Units Affected: 57,816 tubes
Distributed To: Nationwide
Agency Last Updated: September 7, 2022

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.